
Therapeutic could help skin cancer patients avoid surgery
A new therapeutic could help patients with non-melanoma skin cancer avoid immediate surgery, data shows. The Phase II SkinJect dataset, released by biotech company Medicus Pharma, shows microneedle-mediated delivery of doxorubicin led to a response rate of approximately 80%. The study, which compared doxorubicin compared with a… Read More






